Crowell & Moring scored a 100 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Crowell & Moring increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Crowell & Moring forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company supports the Equality Act and funds the Equal Justice Initiative. The firm is Mansfield Certified, indicating its support of DEI in its recruitment, hiring, promotions, and leadership composition. Crowell & Moring is a partner of the Center for Reproductive Rights, building case law, advocating before policy makers, and engaging in litigation to challenge bans and restrictions on access to abortion. The firm is a member of The Diversity and Flexibility Alliance, indicating its support of DEI in its recruitment, retention, promotions, and leadership composition. Crowell & Moring is a member of the MCCA, indicating its focus on recruiting, retaining, and promoting employees based on race. The company is a part of the Law Firm Antiracism Alliance, committed to work on initiatives that fight “systemic racism”. For these reasons, Crowell & Moring receives a High Risk rating.